Characterisation of Antimitotic Products from Marine Organisms That Disorganise the Microtubule Network: Ecteinascidin 743, Isohomohalichondrin-B and LL-15

Overview

Journal Br J Cancer

Specialty Oncology

Date 1996 Apr 1

PMID 8611420

Citations 8

Authors

M Garcia-Rocha

J Avila

Affiliations

Soon will be listed here.

Abstract

The effect of selected marine compounds with anti-tumoral activity on the cell microtubule network was tested by immunofluorescence analyses, or by other in vitro analyses involving competition with colchicine or with GTP for tubulin binding and tubulin polymerisation, studies that were carried out in parallel with other microtubule poisons used as controls. Three compounds were found to disorganise the microtubule network: isohomohalichondrin B, LL-15 and ecsteinascidin 743. The first two compounds prevent microtubule assembly and GTP binding to tubulin. Ecteinascidin 743 disorganises the microtubule network but it does not seem to interact directly with tubulin.

Citing Articles

Cytotoxic Cyclolignans Obtained by the Enlargement of the Cyclolignan Skeleton of Podophyllic Aldehyde, a Selective Podophyllotoxin-Derived Cyclolignan.

Garcia P, Hernandez A, Gomez-Zurita M, Miguel Del Corral J, Gordaliza M, Francesch A Molecules. 2024; 29(7).

PMID: 38611722 PMC: 11013179. DOI: 10.3390/molecules29071442.

Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes.

Barreca M, Spano V, Montalbano A, Cueto M, Diaz Marrero A, Deniz I Mar Drugs. 2020; 18(12).

PMID: 33291602 PMC: 7761941. DOI: 10.3390/md18120619.

Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.

Le V, Inai M, Williams R, Kan T Nat Prod Rep. 2014; 32(2):328-47.

PMID: 25273374 PMC: 4806878. DOI: 10.1039/c4np00051j.

Myeloid-derived cells are key targets of tumor immunotherapy.

Medina-Echeverz J, Aranda F, Berraondo P Oncoimmunology. 2014; 3:e28398.

PMID: 25050208 PMC: 4063142. DOI: 10.4161/onci.28398.

Trabectedin: novel insights in the treatment of advanced sarcoma.

Lopez J, Gajdos C, Elias A Curr Oncol Rep. 2014; 16(6):387.

PMID: 24756367 DOI: 10.1007/s11912-014-0387-z.

References

Wilson L . Properties of colchicine binding protein from chick embryo brain. Interactions with vinca alkaloids and podophyllotoxin. Biochemistry. 1970; 9(25):4999-5007. DOI: 10.1021/bi00827a026. View

Taylor E . THE MECHANISM OF COLCHICINE INHIBITION OF MITOSIS. I. KINETICS OF INHIBITION AND THE BINDING OF H3-COLCHICINE. J Cell Biol. 1965; 25:SUPPL:145-60. PMC: 2106604. DOI: 10.1083/jcb.25.1.145. View

Hoebeke J, Van Nijen G, De Brabander M . Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin. Biochem Biophys Res Commun. 1976; 69(2):319-24. DOI: 10.1016/0006-291x(76)90524-6. View

Himes R, Burton P, Gaito J . Dimethyl sulfoxide-induced self-assembly of tubulin lacking associated proteins. J Biol Chem. 1977; 252(17):6222-8. View

Schiff P, Fant J, Horwitz S . Promotion of microtubule assembly in vitro by taxol. Nature. 1979; 277(5698):665-7. DOI: 10.1038/277665a0. View

Gluzman Y . SV40-transformed simian cells support the replication of early SV40 mutants. Cell. 1981; 23(1):175-82. DOI: 10.1016/0092-8674(81)90282-8. View

Klymkowsky M . Intermediate filaments in 3T3 cells collapse after intracellular injection of a monoclonal anti-intermediate filament antibody. Nature. 1981; 291(5812):249-51. DOI: 10.1038/291249a0. View

WHEELER G, BOWDON B, Werline J, Adamson D, Temple Jr C . Inhibition of mitosis and anticancer activity against experimental neoplasms by ethyl 5-amino-1,2-dihydro-3-[(N-methylanilino)methyl]-pyrido[3,4-b]pyrazin-7-ylcarbamate (NSC 181928). Cancer Res. 1982; 42(3):791-8. View

Osborn M, Weber K . Immunofluorescence and immunocytochemical procedures with affinity purified antibodies: tubulin-containing structures. Methods Cell Biol. 1982; 24:97-132. DOI: 10.1016/s0091-679x(08)60650-0. View

10.

Huang A, Lin C, Hamel E . Maytansine inhibits nucleotide binding at the exchangeable site of tubulin. Biochem Biophys Res Commun. 1985; 128(3):1239-46. DOI: 10.1016/0006-291x(85)91073-3. View

11.

Diez J, Avila J, Nieto J, Andreu J . Reversible inhibition of microtubules and cell growth by the bicyclic colchicine analogue MTC. Cell Motil Cytoskeleton. 1987; 7(2):178-86. DOI: 10.1002/cm.970070210. View

12.

Beck W . The cell biology of multiple drug resistance. Biochem Pharmacol. 1987; 36(18):2879-87. DOI: 10.1016/0006-2952(87)90198-5. View

13.

Moscow J, Cowan K . Multidrug resistance. J Natl Cancer Inst. 1988; 80(1):14-20. DOI: 10.1093/jnci/80.1.14. View

14.

Luduena R, Prasad V, Roach M, Lacey E . The interaction of phomopsin A with bovine brain tubulin. Arch Biochem Biophys. 1989; 272(1):32-8. DOI: 10.1016/0003-9861(89)90191-4. View

15.

Sullivan A, Prasad V, Roach M, Takahashi M, Iwasaki S, Luduena R . Interaction of rhizoxin with bovine brain tubulin. Cancer Res. 1990; 50(14):4277-80. View

16.

Bai R, Pettit G, Hamel E . Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites. J Biol Chem. 1990; 265(28):17141-9. View

17.

Bai R, Paull K, Herald C, Malspeis L, Pettit G, Hamel E . Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. J Biol Chem. 1991; 266(24):15882-9. View

18.

Rowinsky E, Donehower R . The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol Ther. 1991; 52(1):35-84. DOI: 10.1016/0163-7258(91)90086-2. View

19.

Baas P, Pienkowski T, Cimbalnik K, Toyama K, Bakalis S, Ahmad F . Tau confers drug stability but not cold stability to microtubules in living cells. J Cell Sci. 1994; 107 ( Pt 1):135-43. DOI: 10.1242/jcs.107.1.135. View

20.

Flam F . Chemical prospectors scour the seas for promising drugs. Science. 1994; 266(5189):1324-5. DOI: 10.1126/science.7973722. View